Lucira Health, Inc (LHDX)

Etorro trading 970x250

About Lucira Health, Inc

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops testing platform that provides molecular testing services. The company offers LUCIRA COVID- 19 All- In- One Test Kit, that provides COVID- 19 result; and develops influenza A and B viruses test kits. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was founded in 2013 and is headquartered in Emeryville, California. Address: 1412 62nd Street, EmeryVille, CA, United States, 94608

Lucira Health, Inc News and around…

Latest news about Lucira Health, Inc (LHDX) common stock and company :

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lucira Health, Inc. - LHDX
16 Oct, 2021 Yahoo! Finance

Pomerantz LLP is investigating claims on behalf of investors of Lucira Health, Inc. ("Lucira" or the "Company") (NASDAQ: LHDX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

At-home Covid test from East Bay company hit by swab recall
12 Oct, 2021 Yahoo! Finance

The recall is the latest hiccup in a Covid rapid-testing market already stressed by supply chain issues and test failures.

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

LUCIRA™ HEALTH COVID-19 Test Approved for Sale in Singapore
12 Oct, 2021 Yahoo! Finance

Singapore Health Sciences Authority issues approval by its Pandemic Special Access Route (PSAR) for the LUCIRA CHECK IT COVID-19 Test Kit. Lucira has partnered with Labgistics Asia Pte Ltd for the importation and distribution of its products in Singapore.EMERYVILLE, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focusing on the development and commercialization of transformative and innovative infectious di

Lucira Health, Inc. Investors: Company Investigated by the Portnoy Law Firm
11 Oct, 2021 Yahoo! Finance

Investors can contact the law firm at no cost to learn more about recovering their lossesLOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Lucira Health, Inc. ("Lucira" or the "Company") (NASDAQ: LHDX) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss the

35 Biggest Movers From Friday
11 Oct, 2021 FinancialContent

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s ...

28 Stocks Moving In Friday's Mid-Day Session
08 Oct, 2021 FinancialContent

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) ...

LUCIRA™ HEALTH Provides Statement on Copan’s Recall of its FLOQSwabs
08 Oct, 2021 Yahoo! Finance

EMERYVILLE, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today commented on the recent recall of the FLOQSwabs by supply partner Copan Italia SPA, or Copan. Copan, who supplies FLOQSwabs included in the LUCIRA COVID-19 All-In-One Test Kit and LUCIRA CHECK IT COVID-19 Test Kit, collectively the T

Relative Strength Alert For Lucira Health
04 Oct, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

54 Biggest Movers From Friday
04 Oct, 2021 FinancialContent

Check out these big penny stock gainers and losersLosers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to ...

Friday Sector Laggards: Biotechnology, Diagnostics
01 Oct, 2021 FinancialContent

In trading on Friday, biotechnology shares were relative laggards, down on the day by about 1%. Helping drag down the group were shares of Neurobo Pharmaceuticals, off about 29% and shares of Vir Biotechnology off about 21.8% on the day.

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
21 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

LUCIRA™ HEALTH Hires Tony Allen as Chief Operations Officer
20 Sep, 2021 FinancialContent

Veteran operations expert joins Lucira’s management team

LUCIRA™ HEALTH Hires Ghazi Kashmolah as Chief Quality Officer and EVP Regulatory Affairs
23 Aug, 2021 FinancialContent

Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced life science professional Ghazi Kashmolah has joined the company as Chief Quality Officer and Executive Vice President Regulatory Affairs.

3 Beaten-Down Biotech Stocks to Buy Right Now
18 Aug, 2021 FinancialContent

These biotech stocks might be down, but they're not out.

78 Biggest Movers From Friday
16 Aug, 2021 FinancialContent

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported ...

53 Stocks Moving In Friday's Mid-Day Session
13 Aug, 2021 FinancialContent

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The ...

Lucira Health Stock Soars After Q2 Sales Jump 175% Sequentially
13 Aug, 2021 FinancialContent

Lucira Health Inc(NASDAQ: LHDX)reported sales of $12.4 millionin Q2, the firm's second full quarter of ...

Lucira Health, Inc. (LHDX) Q2 2021 Earnings Call Transcript
13 Aug, 2021 FinancialContent

LHDX earnings call for the period ending June 30, 2021.

Lucira Health Announces Second Quarter 2021 Financial Results
12 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
12 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Wednesday Sector Laggards: Consumer Services, Diagnostics
11 Aug, 2021 FinancialContent

In trading on Wednesday, consumer services shares were relative laggards, down on the day by about 5.5%. Helping drag down the group were shares of HyreCar, down about 46.3% and shares of WW International down about 26.4% on the day.

85 Biggest Movers From Yesterday
11 Aug, 2021 FinancialContent

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive ...

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
08 Aug, 2021 FinancialContent

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ...

75 Biggest Movers From Yesterday
04 Aug, 2021 FinancialContent

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company ...

Will Lucira Health (NASDAQ:LHDX) Spend Its Cash Wisely?
03 Aug, 2021 Yahoo! Finance

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Lucira Health to Announce Second Quarter 2021 Financial Results
29 Jul, 2021 FinancialContent
2 Under-the-Radar Stocks to Buy Now
16 Jul, 2021 FinancialContent

The stocks have huge upside potential that investors are overlooking.

5 Stocks to Own for the Surge in Coronavirus Variants
14 Jul, 2021 FinancialContent

Despite easing restrictions, COVID is going to be around a lot longer than many think.

64 Biggest Movers From Yesterday
14 Jul, 2021 FinancialContent

Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday. Red Cat Holdings, ...

Lucira Health, Inc (LHDX) is a NASDAQ Common Stock listed in , ,

970x250